Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
NUKZ is in focus as two pivotal drivers could redefine its trajectory: big-hyperscaler nuclear agreements and the rol...
Ethereum appears to hold a clearer path for near-term traders, while Ripple’s XRP may deliver stronger gains for thos...
In Q1 2026, Alphabet faced a divergent set of moves from top investors: Berkshire Hathaway bought aggressively, while...
The Commerce Department imposed export controls on Anthropic’s latest AI models after a probe described as a narrow j...
A potential shift away from the Fed’s traditional guidance could redefine how markets price risk. If kevin warsh read...
A San Francisco startup is converting floor plans into automated data streams, aiming to speed up loan approvals and ...
A cycle of three Federal Reserve rate cuts has investors rethinking the safety of income from mortgage REITs. Here’s ...
Renaissance Technologies’ Medallion Fund defies the odds by continuing to post extraordinary gains while founder Jim ...
An overnight run on a DeFi vault led to a wind-down after $8.5 million was redeemed, highlighting liquidity risk for ...
J.P. Morgan's strategists raise their year-end S&P 500 view to 7,800, citing stronger earnings and resilient consumer...
Investors and economists are linking AI skepticism to job security and wage growth, not just beliefs about technology...